Opteev’s New Multiplex Biochip Quickly Identifies COVID, Flu, and RSV
The new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
The new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
Visby Medical has received Emergency Use Authorization (EUA) from the U.S. FDA for its Respiratory Health point of care test.
The cost of returning to normal activities may not only be a spike in COVID and the more common coronavirus the “common” cold, but influenza. Testing for both coronaviruses and influenza should be standard operating procedure at the first sign of symptoms.
Visby Medical received $25.5 million in federal funding to develop and validate an at-home combination Flu-Covid test from BARDA.
Read MoreHome-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings.
Read MoreCompass Laboratory Services recently detected two cases of simultaneous infection by the SARS-CoV-2 virus and Influenza A.
Read MoreApplied BioCode has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its BioCode CoV-2 Flu Plus Assay.
Read MoreThe Aptima SARS-CoV-2/Flu Assay from Hologic tests simultaneously for SARS-CoV-2, influenza A, and influenza B on the Panther molecular diagnostics system.
Read MoreLumiraDx has submitted the LumiraDx SARS-CoV-2 & Flu A/B Test to the FDA for Emergency Use Authorization (EUA).
Read MoreIn 2021, as new COVID cases continue, labs could experience the perfect storm of testing for SARS-CoV-2, influenza A and B, and RSV at the same time.
Read MoreGENETWORx provides a combination COVID/influenza/RSV test, and is able to provide follow-up PCR testing after a positive test in 24-48 hours.
Read MoreThe cold and flu viruses that many have avoided while staying at home and social distancing during the COVID-19 pandemic will likely run rampant again as masks come off and schools reopen, reports STAT News.
Read MoreGT Molecular has started shipping its sensitive PCR tests to monitor the coronavirus Delta variant (B.1.617.2) as well as testing and PCR kits for the detection of Influenza A and B.
Read MoreResearchers showed that their testing technology can accurately distinguish between a viral and a bacterial infection for respiratory illness and the test provided results in under an hour.
Read MoreTesting integrates the Spectrum Solutions saliva self-collection system with a new, advanced multiplex qPCR platform for the simultaneous RNA detection of covid-19 and its viral mutations, as well as Influenza A, B, and more.
Read MoreThis winter has been an extraordinarily quiet flu season. Scientists aren’t sure the silence will last, according to a report in The Atlantic.
Read MoreQuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read MoreNew research has shown that implementing point-of-care testing in hospitals to diagnose influenza can lead to better treatment and faster recovery for patients.
Read More